Rezultati - Matthew Bye
- Showing 1 - 2 results of 2
-
1
Transplant Outcomes Using Older Matched Sibling Donors Compared to Young Alternative Donors: A CIBMTR Analysis od Karthik Nath, Mei‐Jie Zhang, Matthew Bye, Muhammad Bilal Abid, Cara L. Benjamin, Brian C. Betts, Neel S. Bhatt, Esteban Arrieta‐Bolaños, Yung‐Tsi Bolon, Shahinaz M. Gadalla, Michael R. Grunwald, Maxwell M. Krem, Stephanie J. Lee, Steven G. E. Marsh, Rodrigo Martino, Parinda A. Mehta, Filippo Milano, Tim Prestidge, Jennifer N. Saultz, Bronwen E. Shaw, Stephen R. Spellman, Hannah Choe, Brian C. Shaffer
Izdano 2025Artigo -
2
Standard-of-Care Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis od Surbhi Sidana, Nausheen Ahmed, Othman Salim Akhtar, Ruta Brazauskas, Temitope Oloyede, Matthew Bye, Doris K. Hansen, Christopher Ferreri, Ciara L. Freeman, Aimaz Afrough, Larry D. Anderson, Binod Dhakal, Devender Dhanda, Lohith Gowda, Hamza Hashmi, Melanie J. Harrison, Amani Kitali, Heather Landau, Abu‐Sayeef Mirza, Pallavi Patwardhan, Muzaffar H. Qazilbash, Saad Z. Usmani, Krina K. Patel, Taiga Nishihori, Siddhartha Ganguly, Marcelo C. Pasquini
Izdano 2025Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Astrobiology
Calcineurin
Chemotherapy
Clinical trial
Cohort
Confidence interval
Cyclophosphamide
Gastroenterology
Graft-versus-host disease
Hazard ratio
Immunology
Multiple myeloma
Oncology
Physics
Proportional hazards model
Refractory (planetary science)
Surgery
Transplantation